Personalis: Karin Eastham

Menlo Park, California-based Personalis has appointed Karin Eastham as independent director to its board of directors. Eastham currently serves as board member for Geron, Veracyte, and Nektar Therapeutics. Prior to Personalis, Eastham served as executive VP and chief operating officer, as well as a member of the board of trustees, at the Burnham Institute for Medical Research from 2004 to her retirement in 2008. She previously served on the boards of Illumina, MorphoSys, Trius Therapeutics, Amylin Pharmacueticals, Genoptix, Tercica, and SGX Pharmaceuticals.